The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

  • STATUS
    Recruiting
  • participants needed
    325
  • sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)
Updated on 17 June 2021
cold
human papillomavirus
colitis
ear infections
adenovirus infection
warts
common cold

Summary

Background
  • Infections caused by viruses are common causes of illnesses: the common cold, many ear infections, sore throats, chicken pox, and the flu are caused by different viruses. Usually, these illnesses last only few days or, at most, a few weeks. Some virus infections like influenza are cleared from the body, and others such as the chicken pox virus remain in the body in an inactive state. However, some people may become quite ill when they are infected with a particular virus, possibly because part of their immune system does not respond properly to fight the virus.
  • Researchers have discovered some reasons why a person may not be able to clear an infection caused by a virus. Some persons have changes in the genes that involve the immune system that result in the inability to properly control infection with a particular virus. Identifying changes in genes that involve the immune system should help scientists better understand how the immune system works to protect people from infection and may help develop new therapies.
    Objectives
  • To study possible immune defects that may be linked to a particular severe viral infection.
  • To determine if identified immune defects are genetic in origin.
    Eligibility
  • Individuals of any age who have or have had a diagnosis of a virus infection that physicians consider to be unusually severe, prolonged, or difficult to treat.
  • Relatives of the participants with a severe viral infection may also participate in the study. We will use their blood and/or skin specimens to try to determine if identified immune defects are hereditary.
    Design
  • Prior to the study, the participant's doctor will give researchers the details of the infection, along with medical records for review. Eligible participants will be invited to the NIH Clinical Center for a full evaluation as an outpatient or inpatient.
  • At the Clinical Center, participants will be treated with the best available therapy for the particular viral infection, and researchers will monitor how the infection responds to the treatment.
  • Researchers will take intermittent blood samples and conduct other tests (such as skin biopsies) to evaluate the immune system. - During and after the illness, researchers will conduct follow-up visits to determine the course of infection and response to therapy.

Description

Viral infections in the normal host are usually self-limited as the innate and acquired immune systems mount successful antiviral responses. However, in some instances, apparently immunocompetent persons manifest infections with viruses that would otherwise be observed only in severely immunocompromised hosts. For example, cases of herpes simplex virus (HSV) encephalitis, esophagitis orgastritis, cytomegalovirus (CMV) colitis, adenovirus hepatitis or pneumonitis, recurrent or persistent skin infections caused by HSV or varicella zoster virus (VZV), severe warts caused by human papillomavirus (HPV), recurrent respiratory papillomatosis caused by HPV, severe influenza or respiratory syncytial virus pneumonia, and progressive multifocal leukoencephalopathy (PML) due to JC polyomavirus have been described in apparently immunocompetent patients. While a variety of case reports have described severe viral infections in immunocompetent hosts, the pathogenesis of the vast majority of these cases is not understood, and therapy can be unsuccessful.

In this protocol, we will evaluate patients without known immunocompromise, who have severe, persistent, or treatment-refractory viral infections caused by herpesviruses, adenoviruses, polyoma viruses, papillomaviruses, or other viral infections. We will investigate whether certain host or virologic factors predispose these individuals to severe disease. We will also determine the usefulness of various microbiologic tests (e.g., cultures, serology, molecular assays) for following the course of infection in these patients. The physicians in the Clinical Center will provide optimal therapy for these patients, as part of standard of care. Identification of virologic or host factors that predispose these patients to severe viral infections may have important implications for elucidating the pathogenesis of infection and for the development of novel therapies.

Details
Condition Varicella-Zoster Virus, Epstein-Barr Virus, Herpes Simplex, human papillomavirus vaccine, Simplexvirus, JC Virus, Cytomegalovirus, Human Papillomavirus Infection, HPV Infection, HCMV Infection, Herpes Simplex Infections, cytomegalovirus infection, hpv vaccine, human papilloma virus vaccine, cmv infection
Clinical Study IdentifierNCT01011712
SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Last Modified on17 June 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

(Participants)
Participants must meet all the following inclusion criteria in order to
participate in this
study
Children or adults (regardless of age) without a known or fully defined immunodeficiency and with a definitively diagnosed severe viral infection, including infection caused by herpesviruses (HSV-1, HSV-2, CMV, EBV, VZV, HHV-6, HHV-7, HHV-8), human papillomavirus (e.g., severe recalcitrant warts), adenovirus, polyomavirus (such as JC virus and BK virus), or influenza virus. Viral infections that would be considered "opportunistic-like", such as herpesvirus esophagitis, herpesvirus encephalitis, CMV colitis, or progressive multifocal leukoencephalopathy (caused by the JC polyoma virus), will be of particular interest in this protocol
OR
Children or adults with a well-documented prior, severe, persistent, or
treatment refractory viral infection(s), who have clinically recovered from
the viral infection
\. Ongoing care by a referring physician
\. Willingness to allow storage of blood and tissue samples for future
analyses
(Relatives)
Relatives (2 years or above) may be recruited to establish the genetic origin
of immune defects that may be identified in the study subjects. We may obtain
blood, buccal swabs or a skin biopsy from the relatives
Males and females will be accepted
Adult relatives or the guardians of minor relatives must be willing and capable of providing informed consent after review of protocol procedures that are described in the consent form with an appropriate study team member
Participating relatives agree to have blood stored for future studies of the immune system

Exclusion Criteria

Participants meeting any of the following exclusion criteria at baseline will
be excluded from study participation
Patients with previously diagnosed conditions associated with immunodeficiency (e.g., a history of HIV infection or a positive test for HIV) or patients with conditions requiring either daily systemic corticosteroids exceeding a dose equivalent to10 mg/day of prednisone or other significant immunosuppressant therapy (e.g., organ or stem cell transplant recipients)
Note: Patients will be included if treatment with steroids or other
immunosuppressive medication was begun to reduce disease associated with the
infection and instituted AFTER the viral disease began
\. Women who are pregnant
\. Any condition or major comorbidity that the study investigators believe
will compromise the patient's ability to comply with the requirements of the
study
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note